Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Flash-Informations
|
September 1, 1985
[Home childbirth today]
C Wasterlain
Brain Research
|
March 14, 1997
Partial protection of hippocampal neurons by MK-801 during perforant path stimulation in the immature brain
K Thompson, C Wasterlain
Brain Research. Developmental Brain Research
|
May 20, 1997
Lithium-pilocarpine status epilepticus in the immature rabbit
K Thompson, C Wasterlain
Epilepsia
|
September 14, 2010
Commentary: translation of laboratory findings to clinic in the treatment of status epilepticus--a mission impossible?
Asla Pitkänen, Claude C Wasterlain
Neurochemical Research
|
January 1, 1988
Decreased calmodulin kinase activity after status epilepticus
J Bronstein, D Farber, C Wasterlain
Neuroscience
|
March 2, 1999
Opioid peptide pharmacology and immunocytochemistry in an animal model of self-sustaining status epilepticus
A Mazarati, H Liu, C Wasterlain
Transactions of the American Neurological Association
|
January 1, 1974
Piribedil--an oral dopamine agonist for treatment of Parkinson's disease
R D Sweet, C Wasterlain, F H McDowell
Proceedings of the National Academy of Sciences of the United States of America
|
July 1, 1990
Effect of septal kindling on glutamate binding and calcium/calmodulin-dependent phosphorylation in a postsynaptic density fraction isolated from rat cerebral cortex
K Wu, C Wasterlain, L Sachs, et al.
Acta Neurologica Scandinavica. Supplementum
|
January 1, 1975
Carbamazepine in difficult to control epileptic out-patients
H Kutt, G Solomon, C Wasterlain, et al.
Advances in Neurology
|
January 1, 1983
Status epilepticus: summary
A V Delgado-Escueta, C Wasterlain, D M Treiman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Flash-Informations
|
September 1, 1985
[Home childbirth today]
C Wasterlain
Brain Research
|
March 14, 1997
Partial protection of hippocampal neurons by MK-801 during perforant path stimulation in the immature brain
K Thompson, C Wasterlain
Brain Research. Developmental Brain Research
|
May 20, 1997
Lithium-pilocarpine status epilepticus in the immature rabbit
K Thompson, C Wasterlain
Epilepsia
|
September 14, 2010
Commentary: translation of laboratory findings to clinic in the treatment of status epilepticus--a mission impossible?
Asla Pitkänen, Claude C Wasterlain
Neurochemical Research
|
January 1, 1988
Decreased calmodulin kinase activity after status epilepticus
J Bronstein, D Farber, C Wasterlain
Neuroscience
|
March 2, 1999
Opioid peptide pharmacology and immunocytochemistry in an animal model of self-sustaining status epilepticus
A Mazarati, H Liu, C Wasterlain
Transactions of the American Neurological Association
|
January 1, 1974
Piribedil--an oral dopamine agonist for treatment of Parkinson's disease
R D Sweet, C Wasterlain, F H McDowell
Proceedings of the National Academy of Sciences of the United States of America
|
July 1, 1990
Effect of septal kindling on glutamate binding and calcium/calmodulin-dependent phosphorylation in a postsynaptic density fraction isolated from rat cerebral cortex
K Wu, C Wasterlain, L Sachs, et al.
Acta Neurologica Scandinavica. Supplementum
|
January 1, 1975
Carbamazepine in difficult to control epileptic out-patients
H Kutt, G Solomon, C Wasterlain, et al.
Advances in Neurology
|
January 1, 1983
Status epilepticus: summary
A V Delgado-Escueta, C Wasterlain, D M Treiman, et al.
Page
of 2